ESG Report 2024

22 Invention Patents 88 Utility Model Patents 10 Exterior Design Patents 23 All production processes and technologies developed of the Group are derived from self-developed research and development, and patents will be applied for each innovative achievement. Before submitting new patent applications, relevant departments will conduct detailed technical searches and reviews to fully understand the intellectual property status of the related technologies or products. The Intellectual Property Affairs Department will conduct simultaneous patent and trademark searches during the intellectual property registration process to enhance the efficiency of patent and trademark registration, and ensure its compliance with laws and regulations and effectiveness. The Group had obtained a total of 121 patents, including 88 invention patents, 10 utility model patents, and 23 exterior design patents. All patents help to protect the interests of the Group. 5.6 Medical Ethics The Group has established a clinical research centre. As a quality control system covering the entire process of clinical trials, the centre is mainly responsible for the clinical development strategy and path formulation, research protocol design, clinical trial organisation and implementation, project management and monitoring, quality control and other related work for all clinical trial projects of the Group. Civil Code of the People's Republic of China Drug Administration Law of the People's Republic of China Measures for the Administration of Drug Registration Quality Control of Clinical Trials of Drugs Measures for Ethical Review of Life Sciences and Medical Research Involving Humans Declaration of Helsinki of the World Medical Association Medical Ethics The United Laboratories Patient Information Protection Policy Regulation on Registration, Review, and Management Policy for Pharmaceutical Representatives Patient Personal Information Protection Policy All clinical trials of the Group strictly complied with the “Declaration of Helsinki of the World Medical Association”, the “Civil Code of the People's Republic of China”, the “Drug Administration Law of the People's Republic of China”, “Measures for the Administration of Drug Registration”, “Quality Control of Clinical Trials of Drugs” and “Measures for Ethical Review of Life Sciences and Medical Research Involving Humans” principles and related ethical requirements, taking the rights and safety of subjects as the primary concern in drug clinical trials. We require all drug clinical trials to obtain a clinical trial license, develop scientific, ethical, compliant and practical clinical trial protocols and work plans, including but not limited to project management plan, inspection plan, data management plan and risk control plan, and set clear provisions for reviewing, verifying and tracing original data, frequency and requirements of inspections, collaborative monitoring, auditing, etc. Clinical trials shall ensure all subjects sign the informed consent forms through examination by the drug clinical trial institution and ethics committee. We are committed to strictly protecting the personal information security of , ensuring the confidentiality of research project data through measures such as anonymisation or coding, thereby reducing the risks and potential harms associated with privacy breaches. At the end of the reporting period, the Group is currently conducting 11 clinical trials for new drugs. Besides, clinical trials of several innovative drugs and biosimilars are about to begin. In the process, we will continuously monitor, inspect, provide feedback and make improvement to ensure the quality, completeness and compliance of the clinical trials. subjects Aspects Regulations and Guidelines Internal Policies Environmental, Social and Governance Report 2024 The United Laboratories International Holdings Limited